DOH allows Sinopharm, Sputnik Light as COVID-19 boosters

Individuals who received Sinopharm for their primary COVID-19 vaccination are now eligible for booster shots.

The Department of Health (DOH) announced that Sputnik Light and Sinopharm have received emergency use authorization as booster doses from the Philippine Food and Drug Administration (FDA).

Sputnik Light can be administered as a booster for those who received AstraZeneca, Moderna, Pfizer, and Sinovac as their primary series, but not as a homologous shot.

Adults fully vaccinated with Sinopharm can receive Sinopharm, AstraZeneca, Moderna, or Pfizer as their booster.

Booster shots are only available to individuals aged 18 and above.

The DOH reassures the public that all vaccines used in the country have undergone rigorous evaluation and have been granted EUA and FDA approval.

Topics in this story

Explore more stories about these topics.

🤖

This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.

News Sources

See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.